Insulet Corporation has announced an extension and amendment to its existing purchase agreement with NXP USA, Inc. through a newly executed addendum effective January 1, 2025. This agreement, originally established on October 12, 2017, and previously amended in 2024, has been further updated to include revisions in pricing, volume commitments, warranties, and product modifications.

The updated terms under the 2025 Addendum reflect an ongoing partnership between Insulet and NXP, ensuring continued supply and collaboration. The full text of the addendum has been filed as an exhibit to the company's Form 8-K, though certain portions have been omitted due to confidentiality provisions under SEC regulations.